Categories: News

CBD of Denver Enhances Shareholder Communications with Appointment of Nicholas Sprung to Its Board

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Denver, Colorado–(Newsfile Corp. – November 30, 2021) – CBD of Denver, Inc. (OTC Pink: CBDD), a cultivator and distributor of CBD and cannabis flower and a producer of a full line of CBD oil and unique products sold in Switzerland and throughout Europe, is pleased to announce the appointment of Nicholas Sprung, the Company’s former President and CEO, to its Board of Directors.

As a Director of CBD of Denver, Sprung is being tasked with enhancing investor communications with both current and prospective shareholders, enabling management to remain focused on the day-to-day operations and growth of the Company.

“I understand the constraints that the management team has faced in Switzerland and their desire to improve shareholder communications,” commented Sprung. “I am pleased to have been invited to return to lead this important initiative as a Director of CBD of Denver. Accurately and clearly communicating the Company’s progress to the investment community is critical to our long-term success, and I look forward to keeping shareholders and potential new investors informed.”

“I am very happy that we have Nicholas back on board, and he is a great asset to the management team,” says Marcel Gamma, CEO of CBD of Denver. “We believe that with Nicholas’ support, we will be able to significantly improve our communications to investors and shareholders and hopefully, over time, strengthen confidence in our company from the investor community.”

Follow CBDD on Instagram: @SwissCBDTrading @Rockflowr @CBDofDenver_Inc @SwissGreenGrow @RockflowrRetail

CBD of Denver, Inc., Rockflowr GmbH and Swiss Industry Ventures AG are now also on LinkedIn.

About CBD of Denver, Inc.

CBD of Denver, Inc. (OTC Pink: CBDD) is a cultivator and distributor of CBD and cannabis flower and a producer of a full line of CBD oil and unique products sold in Switzerland and throughout Europe. CBD of Denver is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for all our shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis. Through our Rockflowr brands we have built a very strong European customer base by focusing on top quality products and meaningful customer relationships. To learn more about CBD of Denver, visit www.cbdofdenver.com.

Information contained herein includes forward-looking statements. These statements relate to future events or future financial performance, involving known and unknown risks and you should not place undue reliance on these statements. Any forward-looking statement reflects our current views with respect to future events. We assume no obligation publicly about update or revise these forward-looking statements for any reason.

Contacts:
Nicholas Sprung
nicholas@cbdofdenver.com

Todd McKnight
RedChip Companies
1-800-733-2447
todd@redchip.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/105832

Staff

Recent Posts

Tebra Launches AI Note Assist, Reducing Clinical Documentation Time by 50% for Independent Practices

New HIPAA-compliant AI technology integrated into Tebra’s EHR platform reduces documentation time by up to…

2 hours ago

New Multicenter Study Demonstrates SyMRI’s Potential to Transform Clinical Neuroimaging Workflows

LINKÖPING, Sweden, June 3, 2025 /PRNewswire/ -- SyntheticMR AB (publ) is proud to share the…

2 hours ago

Asgard Therapeutics strengthens its Board of Directors and Advisory Board with leading experts in drug development and cancer immunotherapy

Highly experienced biopharma executive Dr Cristina Csimma joins Asgard's Board of Directors, while esteemed immunologists…

2 hours ago

Sixth Global Pharma Company Selects LifeSphere NavaX for GenAI-Driven Case Processing

Top 25 Global Life Science Organization Adopts NavaX, Demonstrating Industry Confidence in Scalable, GenAI-Enabled Technologies…

2 hours ago

CareLineLive Secures Majority Investment from Technology Investment Firm Accel-KKR

LONDON and MENLO PARK, Calif., June 3, 2025 /PRNewswire/ -- CareLineLive, an all-in-one home care…

2 hours ago